Eisler Capital (UK)’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-310,294
Closed -$3.07M 345
2022
Q2
$3.07M Buy
310,294
+71,953
+30% +$712K 0.1% 90
2022
Q1
$2.35M Buy
238,341
+5,741
+2% +$56.6K 0.04% 140
2021
Q4
$2.27M Buy
+232,600
New +$2.27M 0.11% 89